REMEDY.HE
Remedy Entertainment Oyj [REMEDY.HE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
REMEDY.HE Stock Summary
Top 10 Correlated Stocks
REMEDY.HE
In the News
REMEDY.HE Financial details
Company Rating
Sell
Market Cap
228.97M
Income
-19.7M
Revenue
48.56M
Book val./share
5.02
Cash/share
2.03
Dividend
0.1
Dividend %
0.39%
Employees
352
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
-284.23
Forward P/E
-
PEG
-2.42
P/S
15.24
P/B
4.22
P/C
8.27
P/FCF
-
Quick Ratio
3.63
Current Ratio
5.53
Debt / Equity
0.03
LT Debt / Equity
-
-
-
EPS (TTM)
-1.66
EPS next Y
-
EPS next Q
-
EPS this Y
1192.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.41%
Revenue Q/Q
103.5%
EPS Q/Q
430%
-
-
-
-
SMA20
-
SMA50
-26.09%
SMA100
-39.29%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-1%
ROC
0.08%
Gross Margin
69%
Oper. Margin
31%
Profit Margin
-5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15.66-30.65
52W High
-44.07%
52W Low
+11.87%
RSI
46
Rel Volume
0.13
Avg Volume
13.47K
Volume
1.79K
Perf Week
-0.36%
Perf Month
4.09%
Perf Quarter
-29.94%
Perf Half Y
-26.72%
-
-
-
-
Beta
0.495
-
-
Volatility
0.12%, 0.3%
Prev Close
1.21%
Price
16.78
Change
1.21%
REMEDY.HE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.62 | 3.4 | 3.43 | 3.26 | 2.52 | |
| Net income per share | 0.43 | 0.86 | 0.67 | -0.13 | -1.68 | |
| Operating cash flow per share | -0.04 | 0.98 | 0.4 | 0.83 | -1.19 | |
| Free cash flow per share | -0.25 | 0.45 | -0.57 | 0.03 | -1.71 | |
| Cash per share | 1.62 | 1.96 | 4.25 | 3.96 | 2.03 | |
| Book value per share | 2.19 | 2.93 | 6.69 | 6.62 | 5.03 | |
| Tangible book value per share | 1.95 | 2.3 | 5.49 | 4.88 | 3.6 | |
| Share holders equity per share | 2.19 | 2.93 | 6.69 | 6.62 | 5.03 | |
| Interest debt per share | 0.32 | 0.34 | 0.31 | 0.24 | 0.28 | |
| Market cap | 138.23M | 470.81M | 517.9M | 291.73M | 342.35M | |
| Enterprise value | 122.35M | 450.8M | 469.27M | 245.68M | 325.95M | |
| P/E ratio | 26.39 | 45.55 | 58.89 | -169.02 | -15.11 | |
| Price to sales ratio | 4.37 | 11.46 | 11.58 | 6.69 | 10.09 | |
| POCF ratio | -280.72 | 39.88 | 99.94 | 26.36 | -21.35 | |
| PFCF ratio | -46.7 | 86.22 | -69.8 | 708.07 | -14.82 | |
| P/B Ratio | 5.24 | 13.3 | 5.93 | 3.3 | 5.05 | |
| PTB ratio | 5.24 | 13.3 | 5.93 | 3.3 | 5.05 | |
| EV to sales | 3.87 | 10.97 | 10.49 | 5.64 | 9.61 | |
| Enterprise value over EBITDA | 16.17 | 31.16 | 29.3 | 167.82 | -19.23 | |
| EV to operating cash flow | -248.48 | 38.18 | 90.56 | 22.2 | -20.33 | |
| EV to free cash flow | -41.34 | 82.55 | -63.25 | 596.32 | -14.11 | |
| Earnings yield | 0.04 | 0.02 | 0.02 | -0.01 | -0.07 | |
| Free cash flow yield | -0.02 | 0.01 | -0.01 | 0 | -0.07 | |
| Debt to equity | 0.14 | 0.1 | 0.03 | 0.03 | 0.05 | |
| Debt to assets | 0.1 | 0.08 | 0.03 | 0.03 | 0.05 | |
| Net debt to EBITDA | -2.1 | -1.38 | -3.04 | -31.45 | 0.97 | |
| Current ratio | 5.27 | 3.71 | 7.26 | 6.78 | 4.45 | |
| Interest coverage | 35.6 | 27.73 | 11.03 | -5.46 | -329.05 | |
| Income quality | -0.09 | 1.14 | 0.59 | -6.41 | 0.71 | |
| Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0.23 | 0.13 | 0.22 | -1.31 | -0.06 | |
| Sales general and administrative to revenue | 0 | 0.03 | 0.22 | 0 | 0.2 | |
| Research and developement to revenue | 0 | 0 | 0.02 | 0 | 0.05 | |
| Intangibles to total assets | 0.08 | 0.16 | 0.16 | 0.23 | 0.24 | |
| Capex to operating cash flow | 5.01 | -0.54 | -2.43 | -0.96 | 0.44 | |
| Capex to revenue | -0.08 | -0.15 | -0.28 | -0.24 | -0.21 | |
| Capex to depreciation | -3 | -5.94 | -6.08 | -4.32 | -0.61 | |
| Stock based compensation to revenue | 0 | 0 | 0.05 | 0.08 | 0 | |
| Graham number | 4.62 | 7.52 | 10.08 | 4.39 | 13.79 | |
| ROIC | 0.17 | 0.27 | 0.13 | -0.02 | -0.32 | |
| Return on tangible assets | 0.16 | 0.25 | 0.1 | -0.02 | -0.38 | |
| Graham Net | 0.9 | 1.7 | 4.58 | 3.33 | 2.13 | |
| Working capital | 24.92M | 27.7M | 67.17M | 58.12M | 34.41M | |
| Tangible asset value | 23.54M | 27.72M | 71.62M | 65.09M | 48.54M | |
| Net current asset value | 21.25M | 24.95M | 65.33M | 56.98M | 32.98M | |
| Invested capital | 0.14 | 0.1 | 0.03 | 0.03 | 0.05 | |
| Average receivables | 541.84K | 7.1M | 17.81M | 13.16M | 10.39M | |
| Average payables | 767.27K | 979.84K | 1.22M | 4.77M | 7.98M | |
| Average inventory | 0.62 | 0.84 | 8.72K | 15.22K | 9.5K | |
| Days sales outstanding | 12.5 | 116.52 | 183.71 | 31.96 | 182.4 | |
| Days payables outstanding | 141.91 | 274.02 | -57.72 | 222.85 | 51.02 | |
| Days of inventory on hand | 0 | 0 | -0.76 | 0.35 | 0.04 | |
| Receivables turnover | 29.2 | 3.13 | 1.99 | 11.42 | 2 | |
| Payables turnover | 2.57 | 1.33 | -6.32 | 1.64 | 7.15 | |
| Inventory turnover | 1.77M | 3.3M | -482.71 | 1.03K | 9.24K | |
| ROE | 0.2 | 0.29 | 0.1 | -0.02 | -0.33 | |
| Capex per share | -0.2 | -0.53 | -0.97 | -0.8 | -0.52 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.83 | 1.02 | 0.59 | 0.66 | 1.34 | |
| Net income per share | -0.05 | 0.11 | -0.31 | -0.2 | -1.06 | |
| Operating cash flow per share | 0.06 | 0.12 | -0.41 | -0.81 | -0.38 | |
| Free cash flow per share | 0.17 | 0.23 | -0.56 | -0.96 | -0.38 | |
| Cash per share | 4.07 | 3.95 | 3.92 | 2.67 | 2.03 | |
| Book value per share | 6.8 | 6.61 | 6.56 | 5.97 | 5.02 | |
| Tangible book value per share | 6.8 | 4.87 | 0 | 4.08 | 5.02 | |
| Share holders equity per share | 6.8 | 6.61 | 6.56 | 5.97 | 5.02 | |
| Interest debt per share | 0.07 | 0.23 | 0 | 0.33 | 0.19 | |
| Market cap | 237.42M | 292.23M | 293.82M | 332.73M | 342.65M | |
| Enterprise value | 188.38M | 246.19M | 346.67M | 308.18M | 326.24M | |
| P/E ratio | -101.37 | 49.6 | -17.68 | -31.19 | -5.97 | |
| Price to sales ratio | 22.05 | 21.45 | 37.16 | 37.37 | 18.91 | |
| POCF ratio | 291.84 | 179.61 | -53.56 | -30.33 | -67.68 | |
| PFCF ratio | 107.38 | 96.62 | -39.25 | -25.65 | -67.68 | |
| P/B Ratio | 2.69 | 3.31 | 3.33 | 4.14 | 5.06 | |
| PTB ratio | 2.69 | 3.31 | 3.33 | 4.14 | 5.06 | |
| EV to sales | 17.5 | 18.07 | 43.84 | 34.62 | 18.01 | |
| Enterprise value over EBITDA | -3.49K | 88.02 | -72.73 | -89.43 | -40.66 | |
| EV to operating cash flow | 231.57 | 151.32 | -63.2 | -28.09 | -64.44 | |
| EV to free cash flow | 85.2 | 81.4 | -46.31 | -23.76 | -64.44 | |
| Earnings yield | 0 | 0.01 | -0.01 | -0.01 | -0.04 | |
| Free cash flow yield | 0.01 | 0.01 | -0.03 | -0.04 | -0.01 | |
| Debt to equity | 0.01 | 0.03 | 0 | 0.05 | 0.03 | |
| Debt to assets | 0.01 | 0.03 | 0 | 0.05 | 0.03 | |
| Net debt to EBITDA | 908.04 | -16.46 | -11.09 | 7.12 | 2.04 | |
| Current ratio | 6.78 | 6.78 | 0 | 5.53 | 4.4 | |
| Interest coverage | 0 | 60.57 | 0 | 26.75 | -60.4 | |
| Income quality | -1.39 | -1.39 | 1.32 | 1.32 | 0.35 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.56 | 0.23 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.23 | 0 | 0.28 | 0 | |
| Capex to operating cash flow | 1.72 | 0.86 | 0.36 | 0.18 | 0 | |
| Capex to revenue | 0.13 | 0.1 | -0.25 | -0.22 | 0 | |
| Capex to depreciation | 1.61 | 1.08 | -4.69 | -1.37 | 0 | |
| Stock based compensation to revenue | 0.17 | 0.13 | 0 | 0 | 0 | |
| Graham number | 2.63 | 4.05 | 6.74 | 5.16 | 10.96 | |
| ROIC | -0.01 | 0.02 | -0.07 | 0.03 | -0.21 | |
| Return on tangible assets | -0.01 | 0.02 | 0 | -0.04 | -0.18 | |
| Graham Net | 3.97 | 3.97 | 3.92 | 2.81 | 2.12 | |
| Working capital | 58.12M | 58.12M | 52.85M | 44.91M | 34.31M | |
| Tangible asset value | 88.36M | 65.09M | 0 | 54.92M | 67.75M | |
| Net current asset value | 56.98M | 56.98M | 52.85M | 42.59M | 32.88M | |
| Invested capital | 0.01 | 0.03 | 0 | 0.05 | 0.03 | |
| Average receivables | 14.18M | 14.22M | 7.65M | 9.41M | 0 | |
| Average payables | 6.81M | 6.14M | 4.1M | 3.95M | 0 | |
| Average inventory | 15.5K | 13K | 6.5K | 5.5K | 0 | |
| Days sales outstanding | 109.71 | 101.1 | 0 | 190.27 | 84.23 | |
| Days payables outstanding | 124.69 | 253.56 | 0 | 172.82 | 4.64 | |
| Days of inventory on hand | 0.4 | 0.4 | 0 | 0.24 | 0.02 | |
| Receivables turnover | 0.82 | 0.89 | 0 | 0.47 | 1.07 | |
| Payables turnover | 0.72 | 0.35 | 0 | 0.52 | 19.41 | |
| Inventory turnover | 226.04 | 224 | 0 | 373.73 | 5.45K | |
| ROE | -0.01 | 0.02 | -0.05 | -0.03 | -0.21 | |
| Capex per share | 0.11 | 0.1 | -0.15 | -0.15 | 0 |
REMEDY.HE Frequently Asked Questions
What is Remedy Entertainment Oyj stock symbol ?
Remedy Entertainment Oyj is a FI stock and trading under the symbol REMEDY.HE
What is Remedy Entertainment Oyj stock quote today ?
Remedy Entertainment Oyj stock price is $16.78 today.
Is Remedy Entertainment Oyj stock public?
Yes, Remedy Entertainment Oyj is a publicly traded company.
Company Profile
- Volume Average 13.47K
- Market Capitalization 228.97M
- Employee 352
- CEO Mr. Tero Virtala
- Headquarters Espoo,FI
- IPO Date 2017-05-29
-
Website
https://www.remedygames.com 
Remedy Entertainment Oyj develops and sells computer and console games in Finland and internationally. It primarily creates story-driven and visually stunning action games. The company was incorporated in 1995 and is based in Espoo, Finland.
